Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance

CVS Health CorpTrade
State Street Real Estate Select Sector SPDR ETFTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs State Street Real Estate Select Sector SPDR ETF — how do they compare? CVS Health Corp trades at $106.29 (market cap $135.48B), while State Street Real Estate Select Sector SPDR ETF trades at $45. The key difference: CVS Health Corp pays a 2.51% dividend while State Street Real Estate Select Sector SPDR ETF pays none. Which is the better fit depends on your goals.

CVSXLRE
Market Cap
$135.48B
Sector
HealthSector/Thematic
52-Week High
$106.18$45.36
52-Week Low
$58.75$40.01
Enterprise Value
$202.02B
Dividend Yield
2.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.

The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.

State Street Real Estate Select Sector SPDR ETF

XLRE, the Real Estate Select Sector SPDR ETF, trades at $44.70 with a 0.56% daily gain, reflecting positive momentum amid a broader real estate sector recovery. Technical indicators show a bullish moving average consensus while oscillators remain neutral. The ETF's low 0.08% expense ratio and 3.4% dividend yield provide cost-efficient real estate exposure. Recent news highlights REITs defying rate pressures with strong 2026 performance, though inflation and Treasury yield volatility remain headwinds.

The outlook for XLRE appears cautiously optimistic as real estate fundamentals improve with steady NOI growth and declining supply. Key opportunities include attractive valuations and potential rate stability, while risks center on interest rate sensitivity and economic slowdowns. With technical strength and sector tailwinds, XLRE offers diversified real estate exposure but requires monitoring of Federal Reserve policy shifts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS

About State Street Real Estate Select Sector SPDR ETF

XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.

Read more on XLRE